The embryonic heart depends on glucose during early organogenesis. Glut-1 f
unctions in constitutive glucose uptake in adult tissues and is the predomi
nant glucose transporter in embryonic and fetal tissues. This study focuses
on Glut-1 expression in the heart during normal organogenesis using irrunu
nohistochemistry for Glut-1 distribution, Western analysis for Glut-1 prote
in levels, and reverse transcriptase polymerase chain reaction for Glut-1 m
RNA levels. The role of Glut in glucose uptake response to hypoglycemia in
the embryonic heart is evaluated using the Glut inhibitor cytochalasin B. C
ardiac Glut-1 expression is also evaluated after in vitro hypoglycemic expo
sure. Glut-1 levels art: highest on gestational days 9-10, intermediate on
gestational day 10.5, and lowest on gestational days 11.5-13.5 in the norma
l embryonic heart. Cardiac Glut-1 mRNA levels similarly decline between ges
tational clays 9.5 and gd 13.5. Cytochalasin B produce:; a dose-dependent d
ecrease in glucose uptake in hearts exposed to hypoglycemia for 30 min or 6
h, implicating Glut in this response. Glut-1 protein expression is unchang
ed after 2 or 6 h but increased after 12 and 24 h of hypoglycemia in the ge
stational day 9.5 heart. Thus, Glut-1 expression is prominent in the embryo
nic heart and is correlated with changes in cardiac glucose requirements du
ring normal organogenesis. Glut activity increases in response to acute hyp
oglycemia and the expression of Glut-1 increases in response to prolonged h
ypoglycemia. These results support the importance of Glut-1 during normal c
ardiogenesis and in response to hypoglycemia in the embryonic heart.